生物标志物 生物标志物
Seungjun Lee1, Wooseok Jung1, Seung Hyun Lee1
1VUNO Inc., Seocho-gu, Seoul, Korea, Republic of (South).
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
概括
这项研究引入了一种新的深度学习框架,该框架使用合成PET扫描来准确预测阿尔茨海默病 (AD) 中的粉样蛋白负担,从而改善早期查的可访问性.
科学领域:
- 神经成像和人工智能的人工智能
- 对神经退行性疾病的生物标志物发现
背景情况:
- 阿尔茨海默氏病 (AD) 诊断依赖于检测粉样β积累,通常使用正子发射断层扫描 (PET) 成像来量化.
- 由于PET扫描的高成本和有限的可用性,阻碍了AD评估的广泛临床应用.
- 现有的粉样蛋白预测深度学习模型通常需要完整的数据集或实际的PET图像,从而限制了它们在现实世界中的实用性.
研究的目的:
- 开发一个掩盖的多式联络多任务深度学习框架,用于预测阿尔茨海默病中的粉样蛋白负担.
- 整合来自MRI产生的合成PET扫描,以克服常规临床实践中的数据限制.
- 提高早期阿尔茨海默病查的准确性和可访问性.
主要方法:
- 分析了来自ADNI-2和ADNI-3研究的968名参与者队列 (2,043次观察) 与纵向MRI,PET,人口统计和临床数据.
- 使用隐性扩散模型 (LDM) 来从MRI序列中生成合成AV45-PET扫描.
- 一个深度学习网络利用合成PET图像和可用的临床数据通过面具嵌入注意力机制来预测粉样蛋白SUVR并分类阳性,处理缺失的输入.
主要成果:
- 拟议的框架实现了连续SUVR预测的0.11的平均绝对误差 (MAE),超过了基线模型 (0.20,0.13,0.13).
- 对于粉样蛋白阳性分类 (SUVR > 1.11),该模型实现了0.93的曲线下面积 (AUC),超过了基线模型 (0.48,0.89,0.90).
- 这种方法有效地处理了缺少的临床数据,并减少了对实际PET扫描的依赖.
结论:
- 开发的深度学习框架通过整合合成PET数据和管理缺失信息,显著提高了对粉样蛋白负担的预测.
- 这种方法有可能通过减少对昂贵的PET成像的依赖,在各种临床环境中扩大早期阿尔茨海默病查的机会.
- 未来的研究将专注于在更大,多样化的队列中验证,并探索使用不同成像追踪器的应用程序,以更广泛地影响AD管理的现实世界.
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516